Usa Germany World Coronavirus Usa Germany

US FDA staff back Pfizer's coronavirus vaccine data

Reading now: 164
www.rte.ie

Pfizer has cleared the next hurdle in the race to get its Covid-19 vaccine approved for emergency use  after the US Food and Drug Administration (FDA) released documents that raised no new issues about its safety or efficacy.

Pfizer and German partner BioNTech submitted data to the FDA last month about their coronavirus vaccine based on data showing the two-dose regimen was 95% effective against Covid-19 and had no major safety issues.

The vaccine's efficacy data met its expectations for emergency use authorisation, FDA staff said in documents released ahead of a Thursday meeting of outside experts to the FDA who will discuss whether to recommend the Pfizer shot for people aged 16 and older.

Read more on rte.ie
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA